Funder: National Institutes of Health
Due Dates (Anticipated): April 2027 | April 2026
Funding Amounts: Award size and total funding not yet specified; cooperative agreement mechanism; details expected at solicitation release.
Summary: Supports multidisciplinary research consortia focused on structure-based immunogen design for HIV prevention and control, advancing broadly neutralizing antibody approaches toward clinical testing.